Decursin inhibits growth of human bladder and colon cancer cells via apoptosis, G1-phase cell cycle arrest and extracellular signal-regulated kinase activation

International Journal of Molecular Medicine

Volumn 25, Issue 4, 2010, Pages 635-641

  Kim, Wun Jae ^a,c   Lee, Se Jung ^b,c   Choi, Young Deuk ^d   Moon, Sung Kwon ^b,c  

^a Chungbuk National University College of Medicine   (South Korea)

^b Chungju National University   (South Korea)

^c Chungbuk National University   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Apoptosis; Bladder cancer cells; Colon cancer cells; Decursin; Extracellular signal regulated kinases; G1 phase cell cycle arrest; p21WAF1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGELICA GIGAS EXTRACT; CASPASE 3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; CYTOCHROME C; DECURSIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DEATH; CELL STRAIN HCT116; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DNA HISTONE INTERACTION; DOWN REGULATION; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOPYRANS; BUTYRIC ACIDS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOCHROMES C; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; PROTEIN KINASE INHIBITORS; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 77749289187     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000386     Document Type: Article

References (31)

1. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD and Coffey RJ: Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nat Med 3: 1233-1241, 1997.
2. Koenig F, Jung K, Schnorr D and Loening SA: Urinary markers of malignancy. Clin Chim Acta 297: 191-205, 2000.
3. Lee S, Shin DS, Kim JS, Oh KB and Kang SS: Antibacterial coumarins from Angelica gigas roots. Arch Pharm Res 26: 449-452, 2003.
4. Sarker SD and Nahar L: Natural medicine: the genus Angelica. Curr Med Chem 11: 1479-1500, 2004.
5. Kim HH, Sik Bang S, Seok Choi J, Han H and Kim IH: Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structureactivity relationship in human K562 erythroleukemia and U937 myeloleukemia cells. Cancer Lett 223: 191-201, 2005.
6. Ahn KS, Sim WS and Kim IH: Decursin: a cytotoxic agent and protein kinase C activator from the root of Angelica gigas. Planta Med 62: 7-9, 1996.
7. Son SH, Kim MJ, Chung WY, Son JA, Kim YS, Kim YC, Kang SS, Lee SK and Park KK: Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase. Cancer Lett 280: 86-92, 2009.
8. Lee S, Lee YS, Jung SH, Shin KH, Kim BK and Kang SS: Antitumor activity of decursinol angulated and decursin from Angelica gigas. Arch Pharmacol Res 26: 727-730, 2003.
9. Yim D, Singh RP, Agrwal C, Lee S, Chi H and Agarwal R: A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res 65: 1035-1044, 2005.
10. Moon SK, Jung SY, Choi YH, Lee YC, Patterson C and Kim CH: PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase. J Cell Physiol 198: 310-323, 2004.
11. Hu W and Kavanagh JJ: Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 4: 721-729, 2003.
12. Yang J, Liu X, Bhalla K, Kim CN, Brado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
13. Nicholson DW, Ali A, Thornberry NA, Thornberry JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle C, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL and Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
14. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994.
15. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809, 1995.
16. Harada H and Grant S: Apoptosis regulators. Rev Clin Exp Hematol 7: 117-138, 2003.
17. Degli Esposti M and Dive C: Mitochondrial membrane permeabilisation by Bax/Bak. Biophys Res Commun 304: 455-461, 2003.
18. Cory S, Huang DC and Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607, 2003.
19. Gross A, Mcdonnell JM and Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
20. Smaili SS, Hsu YT, Sanders KM, Russell JT and Youle RJ: Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential. Cell Death Differ 8: 909-920, 2001.
21. Hsu YT, Wolter KG and Youle RJ: Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis. Proc Natl Acad Sci USA 94: 3668-3672, 1997.
22. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
23. Harnois C, Demers MJ, Bouchard V, Vallee K, Gagne D and Fujit N, Tsuruo T, Vézina A, Beaulieu JF, Côté A and Vachon PH: Human intestinal epithelial crypt cell survival and death: complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways. J Cell Physiol 198: 209-222, 2004.
24. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
25. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
26. Cai K and Dynlacht BD: Activity and nature of p21(WAF1) complexes during the cell cycle. Proc Natl Acad Sci USA 95: 12254-12259, 1998.
27. Sherr CJ and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Gene Dev 9: 1149-1163, 1995.
28. Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268: 14553-14556, 1993.
29. Cobb M and Goldsmith EJ: How MAP Kinases are regulated. J Biol Chem 270: 14843-14846, 1995.
30. Davis RJ: MAPKs: new JNK expands the group. Trends Biochem Sci 19: 470-473, 1994.
31. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.